These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29725274)

  • 1. HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana.
    Simpong DL; Asmah RH; Krampah C; Akakpo PK; Adu P; Asante DB; Naporo S; Adjei AA; Gyasi RK
    ScientificWorldJournal; 2018; 2018():1564150. PubMed ID: 29725274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
    Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
    Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
    Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
    World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
    Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M
    Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
    Koopman T; Smits MM; Louwen M; Hage M; Boot H; Imholz AL
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1343-51. PubMed ID: 25544671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epidermal growth factor receptor 2 overexpression in gastric and gastroesophageal junction adenocarcinoma in patients seen at the University Teaching Hospital, Lusaka, Zambia.
    Kasochi C; Julius P; Mweemba I; Kayamba V
    Afr Health Sci; 2020 Dec; 20(4):1857-1864. PubMed ID: 34394249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in Gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
    Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
    West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases.
    Schoppmann SF; Jesch B; Zacherl J; Wrba F; Hejna M; Maresch J; Langer FB; Riegler MF; Pluschnig U; Birner P
    Br J Surg; 2011 Oct; 98(10):1408-13. PubMed ID: 21618213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of Human Epidermal Growth factor receptor-2 [HER-2] in Carcinoma Oesophagus [Single Institutional Tertiary cancer centre study from North-East part of India].
    Kalita D; Bannoth S; Purkayastha J; Talukdar A; Das G
    Indian J Pathol Microbiol; 2021; 64(1):47-51. PubMed ID: 33433408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas.
    Griffiths EA; Pritchard SA; Valentine HR; Whitchelo N; Bishop PW; Ebert MP; Price PM; Welch IM; West CM
    Br J Cancer; 2007 Jan; 96(1):95-103. PubMed ID: 17179985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 amplification status in gastric and gastro-oesophageal junction cancer in routine clinical practice: which sample should be used?
    Perrone G; Amato M; Callea M; Rabitti C; Righi D; Crucitti P; Coppola R; Onetti Muda A
    Histopathology; 2012 Jul; 61(1):134-5. PubMed ID: 22551459
    [No Abstract]   [Full Text] [Related]  

  • 13. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis.
    Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M
    Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival.
    Dreilich M; Wanders A; Brattström D; Bergström S; Hesselius P; Wagenius G; Bergqvist M
    Dis Esophagus; 2006; 19(4):224-31. PubMed ID: 16866851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas.
    Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D
    Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation.
    Betts G; Valentine H; Pritchard S; Swindell R; Williams V; Morgan S; Griffiths EA; Welch I; West C; Womack C
    Virchows Arch; 2014 Feb; 464(2):145-56. PubMed ID: 24306956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CMET is associated with signal transducer and activator of transcription 3 activation and diminished prognosis in oesophageal adenocarcinoma but not in squamous cell carcinoma.
    Mesteri I; Schoppmann SF; Preusser M; Birner P
    Eur J Cancer; 2014 May; 50(7):1354-60. PubMed ID: 24565853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of HER-2/NEU-CERBB-2 in patients with adenocarcinoma of the stomach.
    Cirne-Lima FK; Rosa Ade S; Kulczynski JM; Mattana DS; Corezolla K; Moreira LF
    Rev Col Bras Cir; 2009 Apr; 36(2):131-4. PubMed ID: 20076883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.